Article ID Journal Published Year Pages File Type
3901816 Urology 2012 9 Pages PDF
Abstract
The combination of ritonavir and bortezomib inhibits renal cancer growth synergistically. The effectiveness of the combination is caused by protein ubiquitination and histone acetylation. Our results provide a rationale for investigating the combination in patients with renal cancer.
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Preview
Ritonavir Interacts With Bortezomib to Enhance Protein Ubiquitination and Histone Acetylation Synergistically in Renal Cancer Cells
Authors
, , , ,